The Moving Average Convergence Divergence (MACD) for EDGE turned positive on December 19, 2025. Looking at past instances where EDGE's MACD turned positive, the stock continued to rise in of 8 cases over the following month. The odds of a continued upward trend are .
The Momentum Indicator moved above the 0 level on December 19, 2025. You may want to consider a long position or call options on EDGE as a result. In of 9 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
EDGE moved above its 50-day moving average on November 28, 2025 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for EDGE crossed bullishly above the 50-day moving average on December 04, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 1 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where EDGE advanced for three days, in of 36 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 83 cases where EDGE Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The RSI Indicator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where EDGE declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
EDGE broke above its upper Bollinger Band on December 23, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
a developer of linical-stage immunotherapies to treat various early-stage and late-stage cancers which includes head & neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer and related cancers
Category Trading